MedPath

四川金信康达医药科技有限公司

Ownership
-
Established
2022-08-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Cilostazol Tablets

Product Name
西洛他唑片
Approval Number
国药准字H20113551
Approval Date
Dec 23, 2021
NMPA

Colloidal Bismuth Pectin Capsules

Product Name
胶体果胶铋胶囊
Approval Number
国药准字H20064273
Approval Date
Aug 18, 2021
NMPA

Colloidal Bismuth Pectin Capsules

Product Name
胶体果胶铋胶囊
Approval Number
国药准字H20063860
Approval Date
Aug 18, 2021
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H51023562
Approval Date
Aug 12, 2020
NMPA

回春如意胶囊

Approval Number
国药准字Z14021829
Approval Date
Apr 7, 2020
NMPA

Gemfibrozil Capsules

Product Name
吉非罗齐胶囊
Approval Number
国药准字H14020050
Approval Date
Apr 7, 2020
NMPA

Terazosin Hydrochloride Capsules

Product Name
盐酸特拉唑嗪胶囊
Approval Number
国药准字H20103408
Approval Date
Apr 7, 2020
NMPA

Bisacodyl Enteric-coated Tablets

Product Name
比沙可啶肠溶片
Approval Number
国药准字H20057029
Approval Date
Apr 7, 2020
NMPA

润肠通便茶

Approval Number
国药准字B20020980
Approval Date
Apr 7, 2020
NMPA

Telmisartan Tablets

Product Name
隆舒雅
Approval Number
国药准字H20050837
Approval Date
Apr 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.